期刊文献+

尿核基质蛋白22对膀胱移行上皮癌的诊断价值

下载PDF
导出
摘要 目的 :评估尿核基质蛋白 2 2 (NMP2 2 )对诊断膀胱移行上皮癌 (BTCC)或对膀胱移行上皮癌术后复发监测的价值。方法 :用酶联免疫分析法测定 4 8例BTCC患者及 2 0例非BTCC患者尿样中NMP2 2的含量。结果 :BTCC患者尿NMP2 2阳性率为 79.2 % ,且与分级无关 ,2 0例非BTCC患者仅 1例阳性。结论 :尿NMP2 2的含量测定敏感性及特异性强 ,且方便、无创 。
出处 《温州医学院学报》 CAS 2002年第4期245-246,共2页 Journal of Wenzhou Medical College
  • 相关文献

参考文献7

  • 1[1]Droller MJ. Bladder cancer: state-of-the-art care[J]. CA Cancer J Clin, 1998,48: 269 - 284.
  • 2[2]Soloway MS, Briggman JV, Carpinito GA, et al. Use of a new tumor marker, urinary NMP22, in the detection of oocult or rapidly recurringtransitional cell carcinoma of the urinary tract following surgical treatment[J]. J Urol, 1996,156:363 - 367.
  • 3[3]Berezney R, Coffey DS. Identifiction of a nuclear protein matrix[J].Biochea Biophys Res Commn, 1974,60:1410.
  • 4[4]Fey EG, Penman S. Nuclear martix pruteins reflect cell type of origin in cultured human Cell[J] .Proc Acad Sci USA, 1988,85:121.
  • 5[5]Keesee Sk, Briggman JV, Thill, GA, etal. Utilization of mclear matrix proteins for cancer diagnosis [ J]. Crit Rev Eularyot Gene Expr, 1996,6:189-241.
  • 6[6]Del Nero A. Esposito N, Currro A, et al. Evaluation of urinary level of NMP22 as a diagnostic marker for stage pTa-PT1 bladder cancer: comparrison with urinary cytology and BTA test[J]. Eur Urol, 1999,35:93.
  • 7[7]Sharma S, Zippe CD, Pandrangi L, et al. Exclusion criteria enhance thespecificity and positive predictive value of NMP22 and BTA stat[J]. J Urol,1999,162(1):53-57.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部